(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.93%) $83.07
(-1.16%) $1.619
(-0.26%) $2 341.00
(0.07%) $27.56
(0.57%) $927.40
(-0.17%) $0.933
(-0.15%) $11.01
(-0.24%) $0.798
(0.00%) $92.17
Live Chart Being Loaded With Signals
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong...
Stats | |
---|---|
आज की मात्रा | 1.37M |
औसत मात्रा | 9.19M |
बाजार मूल्य | 32.04B |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0.160 ( 2023-06-05 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 7.73 |
ATR14 | HKD0.0130 (0.26%) |
मात्रा सहसंबंध
China Resources सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
China Resources सहसंबंध - मुद्रा/वस्त्र
China Resources वित्तीय
Annual | 2023 |
राजस्व: | HKD270.40B |
सकल लाभ: | HKD42.36B (15.67 %) |
EPS: | HKD0.680 |
FY | 2023 |
राजस्व: | HKD270.40B |
सकल लाभ: | HKD42.36B (15.67 %) |
EPS: | HKD0.680 |
FY | 2022 |
राजस्व: | HKD254.11B |
सकल लाभ: | HKD39.13B (15.40 %) |
EPS: | HKD0.660 |
FY | 2021 |
राजस्व: | HKD236.81B |
सकल लाभ: | HKD35.38B (14.94 %) |
EPS: | HKD0.600 |
Financial Reports:
No articles found.
China Resources Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.160 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0900 | 2017-05-24 |
Last Dividend | HKD0.160 | 2023-06-05 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 8 | -- |
Total Paid Out | HKD0.980 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.49 | -- |
Div. Sustainability Score | 8.46 | |
Div.Growth Potential Score | 4.24 | |
Div. Directional Score | 6.35 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2327.HK | Ex Dividend Junior | 2023-08-03 | Sporadic | 0 | 0.00% | |
1290.HK | Ex Dividend Junior | 2023-06-14 | Sporadic | 0 | 0.00% | |
0363.HK | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% | |
6117.HK | Ex Dividend Junior | 2023-05-22 | Sporadic | 0 | 0.00% | |
1857.HK | Ex Dividend Junior | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
0881.HK | Ex Dividend Junior | 2023-06-23 | Annually | 0 | 0.00% | |
0026.HK | Ex Dividend Junior | 2023-10-03 | Semi-Annually | 0 | 0.00% | |
2669.HK | Ex Dividend Knight | 2023-06-23 | Semi-Annually | 0 | 0.00% | |
1428.HK | Ex Dividend Knight | 2023-08-23 | Annually | 0 | 0.00% | |
0518.HK | Ex Dividend Junior | 2023-09-01 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0158 | 1.500 | 9.68 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0156 | 1.200 | 9.48 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0800 | 1.500 | -0.222 | -0.334 | [0.1 - 1] |
payoutRatioTTM | 0.245 | -1.000 | 7.55 | -7.55 | [0 - 1] |
currentRatioTTM | 1.330 | 0.800 | 8.35 | 6.68 | [1 - 3] |
quickRatioTTM | 0.799 | 0.800 | -0.00494 | -0.00395 | [0.8 - 2.5] |
cashRatioTTM | 0.236 | 1.500 | 9.80 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.313 | -1.500 | 4.79 | -7.19 | [0 - 0.6] |
interestCoverageTTM | 4.41 | 1.000 | 9.48 | 9.48 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.555 | 2.00 | 9.48 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.054 | 2.00 | 9.47 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.678 | -1.500 | 3.29 | -4.93 | [0 - 2.5] |
grossProfitMarginTTM | 0.157 | 1.000 | -0.722 | -0.722 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0431 | 1.000 | -1.139 | -1.139 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.127 | 1.000 | -0.407 | -0.407 | [0.2 - 2] |
assetTurnoverTTM | 0.992 | 0.800 | 6.72 | 5.38 | [0.5 - 2] |
Total Score | 8.46 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.22 | 1.000 | 9.27 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0800 | 2.50 | -0.143 | -0.334 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.054 | 2.00 | 9.65 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.17 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.555 | 2.00 | 9.48 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.245 | 1.500 | 7.55 | -7.55 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0399 | 1.000 | -1.502 | 0 | [0.1 - 0.5] |
Total Score | 4.24 |
China Resources
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. It offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. The company also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it is involved in property holding activities. As of December 31, 2021, the company operated 801 retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं